A prospective single-centre study found that 97 percent of 304 outpatients with low-risk drug allergy labels had no reaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results